INDEPENDENT NEWS

Business, Regulatory and Patents Digest

Published: Mon 16 Feb 2004 05:26 PM
Business, Regulatory and Patents Digest
Cogitations: Business, Regulatory and Patents 16 February 2004 Guest Editorial - Business, Regulatory and Patents 16 February 2004 Research charity secures cancer gene patent EC to ask for GM corn approval German cabinet approves GM Bill Genesis result no cause for alarm, exec says Future bright for local drug industry, Professor says Relax rules on embryo use, scientists say
Cogitations: Business, Regulatory and Patents 16 February 2004 Last week the British medical charity, Cancer Research UK, announced it had secured the European patent on a gene that causes hereditary breast cancer. The patent covers all efforts to sequence the Stand up for your rights!Oops, they've done it again; our Government does not seem capable of presenting a consistent message, no matter the subject. On a current topical issue, we have Solici... More... http://www.BioSciNews.com/files/news-detail.asp?newsID=6246
Research charity secures cancer gene patent A British medical research charity announced Wednesday it has secured a Europe-wide patent on a key gene that causes hereditary breast cancer, saying it had won a victory that ensures that cancer rese... More... http://www.BioSciNews.com/files/news-detail.asp?newsID=6182
EC to ask for GM corn approval The European Commission on Wednesday will ask national governments to approve the sale of a gene-modified corn made by Monsanto Co., pressing ahead with efforts to lift the region's six-year ban on ne... More... http://www.BioSciNews.com/files/news-detail.asp?newsID=6201
German cabinet approves GM Bill German Chancellor Gerhard Schröder's cabinet on has approved a bill regulating the cultivation of genetically modified organisms. The bill would make it legal for German farmers and supermarkets to se... More... http://www.BioSciNews.com/files/news-detail.asp?newsID=6221
Genesis result no cause for alarm, exec says New Zealand's largest listed biotech company, Genesis Research, has enough cash to survive just two more years unless it can significantly reduce costs or boost revenue. The company has reported a... More... http://www.BioSciNews.com/files/news-detail.asp?newsID=6230
Future bright for local drug industry, Professor says University of Otago pharmacy school dean Professor Ian Tucker believes New Zealand's pharmaceutical industry can eventually achieve major international success. Professor Tucker was one of several... More... http://www.BioSciNews.com/files/news-detail.asp?newsID=6229
Relax rules on embryo use, scientists say New Zealand researchers want the right to destroy human embryos in order to grow stem cells that might one day provide cures for conditions such as Parkinson's disease. A lineup of scientists at t... More... http://www.BioSciNews.com/files/news-detail.asp?newsID=6237

Next in Business, Science, and Tech

Commission welcomes dismissal of NZME/Fairfax merger appeal
By: Commerce Commission
New Chief Technology Officer role created
By: New Zealand Government
Beef + Lamb New Zealand launches drought resources
By: NZ Beef and Lamb
Net Neutrality Failure in US Will Hurt All Internet Users
By: Internet NZ
Technology transforms consumer spending
By: Statistics New Zealand
Results Judgment: NZME merger appeal dismissed
By: New Zealand High Court
NZME, Fairfax reviewing rejected merger appeal
By: BusinessDesk
High Court rejects NZME/Fairfax NZ appeal
By: BusinessDesk
Minister silent while farmers wilt
By: New Zealand National Party
Westpac NZ Offers Relief to Farmers Affected by Drought
By: Westpac
Fronts and fine weather in the mix
By: MetService
2017 Worst Year on Record for Weather-Related Losses
By: Insurance Council
Net neutrality in New Zealand
By: Digitl
View as: DESKTOP | MOBILEWe're in BETA! Send Feedback © Scoop Media